Viewing nowCombinationPosidabe Tablet 10/100 mg
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
LightPharmTech Co., Ltd.

MFDS item code 202200052 · Approved 2022.01.04 · Insurance code 690303480
Improvement in blood sugar control in type 2 diabetes
This medication helps patients with type 2 diabetes achieve better blood sugar control while following dietary and exercise therapies. The two active ingredients, sitagliptin and dapagliflozin, work together to help stabilize blood sugar levels. It is especially suitable for those who struggle with blood sugar control with monotherapy. Continuous use can improve blood sugar management and help prevent complications. This medication is used for blood sugar control in type 2 diabetes.
For patients receiving 100 mg of sitagliptin and 10 mg of dapagliflozin, one tablet may be taken once daily, regardless of meals. The tablet should be swallowed whole.
This medication can cause severe allergic reactions within the first 3 months of use; therefore, if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, you must stop using the medication immediately and consult a physician. This medication carries the risk of pancreatitis, which is inflammation of the pancreas; therefore, if severe abdominal pain or vomiting occurs, you should inform medical personnel immediately. This medication should not be used in individuals with allergies to specific ingredients, in patients with type 1 diabetes, or in patients undergoing dialysis. Patients with impaired kidney function or decreased fluid volume should have their kidney function and blood pressure periodically monitored while using this medication, and caution is advised if symptoms of hypotension occur. This medication can increase the risk of genital infections and urinary tract infections, so if infection symptoms appear, immediate treatment is necessary. There is a risk of serious metabolic conditions such as diabetic ketoacidosis; contact medical personnel immediately if symptoms like vomiting, abdominal pain, difficulty breathing, or lethargy occur. When administering to older adults, regularly assess kidney function and pay special attention to fluid volume depletion or symptoms of hypoglycemia. Pregnant or breastfeeding women should refrain from using this medication, and if pregnancy is confirmed, use should be discontinued immediately. Caution is necessary while driving or operating machinery, as there is a risk of hypoglycemia during use. In the case of overdose, there are no specific antidotes, so appropriate treatment based on symptoms should be provided, and in severe cases, dialysis may be needed. This medication should be stored in its original container, out of reach of children.
Hives, severe swelling (angioedema), anaphylaxis, severe skin adverse reactions (Stevens-Johnson syndrome, exfoliative dermatitis, pemphigus-like blistering), acute pancreatitis, hemorrhagic or necrotizing pancreatitis, difficulty breathing, asthma attacks, jaundice, liver abnormalities, sudden and severe headache, seizures, confusion, visual disturbances, paralysis, acute renal failure, elevated blood pressure, and severe swelling, marked decrease in urine output, perineum
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it should be stored in a sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the efficacy and safety of the medication for an extended period.
Bright yellow rectangular film-coated tablet
Box - 30 tablets/box [(10 tablets/Alu-Alu x 3)], Box - 28 tablets/box [(7 tablets/Alu-Alu x 4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
LightPharmTech Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.